This CME activity has reached its termination date and no longer offers continuing education credit. Please note that expired CME activities may not contain the most up-to-date information available.
Click here to view our current activities in Neurology.
Daily Highlights from the APSS 18th Annual Meeting
This 5-part, multimedia CME activity offers insights from renowned experts in sleep medicine on the latest data on the diagnosis and treatment of Restless Legs Syndrome (RLS), and includes the following components:
This activity is designed for clinicians who treat patients with sleep disorders.
Activity Goal
The goal of Expert Perspectives in RLS: News and Views from the 2004 Associated Professional Sleep Societies (APSS) Annual Meeting is to provide clinicians with the key clinical data and insights on the diagnosis and treatment of RLS from the APSS annual meeting.
Series Objectives (based on content from all 5 parts of the series)
Incorporate the latest data on RLS epidemiology, and genetics and other risk factors, into identification and diagnosis of patients at risk for the disease.
Differentiate between RLS and other disorders such as peripheral neuropathy based on clinical presentation and the results of polysomnography.
Identify RLS in special populations, including children, pregnant women, and patients with other conditions such as ADHD.
Formulate diagnosis and treatment strategies for patients with co-morbid disease.
Develop an effective RLS treatment plan based on safety and efficacy data of available therapies.
Translate an understanding of the latest data on RLS pathophysiology into selection of appropriate treatment strategies.
CME Information
Statement of Accreditation
Projects In Knowledge is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
Projects In Knowledge designates this educational activity for a maximum of 3.5 Category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
This 5-part series is planned and implemented as an independent CME activity in accordance with the ACCME Essential Areas and Policies.
The Disclosure Policy of Projects In Knowledge requires that faculty participating in a CME activity disclose to the audience: any significant relationship they may have with a pharmaceutical or medical equipment company, product, or service that may be mentioned as part of their presentation; any relationship with the commercial supporter of this activity; if discussion includes 1) therapies that are unapproved for use or are investigational; 2) ongoing research; or 3) preliminary data. Faculty will disclose such discussion.
For complete prescribing information on the products discussed during this CME activity, please see your current Physicians' Desk Reference (PDR).
This activity will include a discussion of the investigational uses of gabapentin, levetiracetam, lisuride, oxcarbazepine, pramipexole, ropinirole, and trazodone in RLS.
Philip M. Becker, MD, has received grant/research support from Aventis Pharmaceuticals Inc, Cephalon, Inc, GlaxoSmithKline, Orphan Medical, Inc, Pfizer Inc, and Sanofi-Synthelabo; is a consultant for Cephalon, Inc, and GlaxoSmithKline; and is on the speakers bureau of Cephalon, Inc, GlaxoSmithKline, Orphan Medical, Inc, Pfizer Inc, and Sanofi-Synthelabo.
Clete A. Kushida, MD, PhD, has received grant/research support from GlaxoSmithKline and Pharmacia & Upjohn; is a consultant for Pharmacia & Upjohn; and is on the speakers bureau of GlaxoSmithKline and Pharmacia & Upjohn.
Barbara A. Phillips, MD, MSPH, is a consultant for GlaxoSmithKline.
Peer Reviewer has indicated no significant relationships.
The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge.
This CME activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the physician caring for the patient.
This independent CME activity is supported by an educational grant from GlaxoSmithKline.